<qa>  What is the duration of treatment with any investigational drug within 30 days or 5 half-live17. Treatment with any investigational drug within 30 days or 5 half-lives whichever is longer prior to the beginning of the screening period this includes investigational formulations of marketed products, inhaled and topical drugs 